The Food and Drug Administration said Tuesday data from Pfizer’s coronavirus vaccine trials was “consistent” with recommendations put forth by the agency for an emergency use authorization, adding the vaccine was highly effective and did not raise any specific safety concerns.
Trending:
FDA says Pfizer COVID vaccine provides some protection after first dose, meets success criteria